Commentary: New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the MT-ND4 Gene (m.12015T>C; p.Leu419Pro) and Comorbid Polyglandular Autoimmune Syndrome Type 2
Main Author: | Josef Finsterer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01333/full |
Similar Items
-
New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the MT-ND4 Gene (m.12015T>C; p.Leu419Pro) and Comorbid Polyglandular Autoimmune Syndrome Type 2
by: Dominique Endres, et al.
Published: (2019-03-01) -
Commentary: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with an MT-TL1 m.3243A>G point mutation: neuroradiological features and their implications for underlying pathogenesis
by: Josef Finsterer, et al.
Published: (2023-04-01) -
Optimising therapeutic strategies for acute stroke-like lesions in MELAS
by: Josef Finsterer
Published: (2020-12-01) -
Recent Advances in Detecting Mitochondrial DNA Heteroplasmic Variations
by: Mengqin Duan, et al.
Published: (2018-02-01) -
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
by: John P Grady, et al.
Published: (2018-06-01)